HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and hypoxic-cytotoxic activity of some 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.

Abstract
A series of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives 1 have been synthesized and evaluated for their cytotoxic activity in vitro against human leukemia cell lines: Molt-4, K562, HL60, human liver cancer cell Hep-G2, human prostate cancer cell PC-3 in hypoxia. Most of the compounds showed more potent activity than TPZ. Compounds 1i and 1m displayed encouraging superior activity against Molt-4 and HL-60 cell lines. Three potential derivatives received the test of the activity in hypoxia and in normoxia against Molt-4 and HL-60 cell lines and showed obvious hypoxia selectivity. Further mechanism study revealed that the cytotoxic activities of compounds 1i and 1k in Molt-4 cells might be mediated by modulation of p53 protein expression and mitochondrial membrane potential (DeltaPsi(m)).
AuthorsFaqin Jiang, Bo Yang, Lingling Fan, Qiaojun He, Yongzhou Hu
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 16 Issue 16 Pg. 4209-13 (Aug 15 2006) ISSN: 0960-894X [Print] England
PMID16777409 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Triazines
  • Tumor Suppressor Protein p53
  • Tirapazamine
Topics
  • Antineoplastic Agents (pharmacology)
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • HL-60 Cells
  • Humans
  • Hypoxia
  • Inhibitory Concentration 50
  • K562 Cells
  • Membrane Potentials
  • Models, Chemical
  • Tirapazamine
  • Triazines (chemical synthesis, chemistry, pharmacology)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: